Agomelatine

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac sustained release tablets 200 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes aceclofenac tablets 100 mg. It belongs to antiinflammatory / antiarthritis finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes acyclovir. It belongs to lypholised powder ready to fill category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adapalene. It belongs to antiacne apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adapalene and clindamycin gel (0.1 + 1) % w/w. It belobgs to dermotology finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes adefovir. It belongs to antiretroviral apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes alendronate sodium. It belongs to antiosteoporosis apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes alfacalcidol. It belongs to antiosteoporosis apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes alfuzosin hcl. It belongs to treating benign prostatic hyperplasia ( bph ) apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes amphotericin b (liposomal) for injection 50 mg. It belongs to antifungal finish formulations products category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes anastrazole. It belongs to antineoplastic apis category. Contact us for more information.

Bdr pharmaceuticals international pvt manufactures a pharmaceutical apis, intermediates, finish formulations which includes anastrazole 1mg tabs. It belongs toanticancer ( oral / injection) finish formulations products category. Contact us for more information.

Dharmesh Shah, Chairman & Managing Director of BDR Pharmaceuticals, speaks with CPHI TV at CPHI Worldwide in Madrid.